cobaltous chloride has been researched along with Animal Mammary Carcinoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| An, JH; Kim, KB; Kim, TH; Ko, BG; Lee, JH; Youn, HY | 1 |
| Borin, TF; Carvalho, LGS; de Campos Zuccari, DAP; Ferreira, LC; Gelaleti, GB; Hellmén, E; Jardim-Perassi, BV; Leonel, C; Maschio-Signorini, LB; Moschetta, MG; Sonehara, NM | 1 |
| Alayoubi, AY; Ananthula, S; Behery, FA; El Sayed, K; Nazzal, S; Parajuli, P; Sylvester, PW | 1 |
3 other study(ies) available for cobaltous chloride and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Hypoxia Increases the Proliferative and Metastatic Ability of Canine Mammary Tumor Cells
Topics: Animals; Dogs; Hypoxia; Mammary Neoplasms, Animal; Mitosis; Up-Regulation | 2022 |
Evaluation of Angiogenesis Process after Metformin and LY294002 Treatment in Mammary Tumor.
Topics: Animals; Cell Line, Tumor; Chromones; Cobalt; Dog Diseases; Dogs; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Mammary Neoplasms, Animal; Metformin; Mice; Mice, Inbred BALB C; Mice, Nude; Morpholines; Neovascularization, Pathologic; Oxygen; Vascular Endothelial Growth Factor A | 2019 |
δ-Tocotrienol oxazine derivative antagonizes mammary tumor cell compensatory response to CoCl2-induced hypoxia.
Topics: Animals; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cobalt; Female; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mammary Neoplasms, Animal; Mice; Signal Transduction; Vitamin E | 2014 |